Form D · Pharmaceuticals
NeuroGenetic Pharmaceuticals, Inc.
Del Mar, CA · CIK 0001496298
Offering snapshot reported Mar 12, 2015 · SEC filing
- Reported sold
- $50K Offering amount: $60K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 25, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 12, 2015 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Jan 9, 2014 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Oct 1, 2012 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Dec 28, 2011 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jul 12, 2010 | Initial | $1,144,878 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-235783
Includes estimated amount receivable by the Issuer upon exercise of a warrant to purchase the Issuer's Preferred Stock; such warrant has not yet been exercised.
Source: Form D, filed Mar 12, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William T. Comer | Director, Executive |
| Barry Quart | Director |
| Tom Reed | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
445 Marine View Avenue, Suite 101
Del Mar, CA, 92014
Del Mar, CA, 92014